Literature DB >> 11320502

Renal tubular function by lithium clearance in liver cirrhosis.

P Anastasio1, A Frangiosa, T Papalia, N De Napoli, L Capodicasa, C Loguercio, C Del Vecchio Blanco, N G De Santo.   

Abstract

Increased tubule sodium reabsorption has been largely suspected in liver cirrhosis (LC), however studies in humans have produced contrasting results. Therefore to ascertain the entity of renal sodium handling in LC this study was devised. A total of 13 patients with child A LC were studied along with 26 age-sex matched healthy controls (HC). Patients and controls were kept on daily Na-intake of 100 mmol for at last 1 week, by measuring glomerular filtration rate (GFR; inulin) and lithium clearance. We have calculated (1) C(Li); (2) the absolute reabsorption of isotonic fluid in the proximal tubule (APR) as GFR - C(LI); (3) the fractional proximal sodium reabsorption (FPRNa) as 1 - (C(Li)/GFR); (4) the absolute distal reabsorption of sodium (ADRNa) as (C(LI) - C(Na)) x P(Na;) and (5) the fractional distal sodium reabsorption (FDRNa) as (C(LI) - C(Na))/C(Li). GFR was significantly lower in LC (P<.001), C(Li) was significantly higher in LC than in HC (P<.001). APRNa and FPRNa were reduced in LC (P<.0001). ADRNa was higher in LC than in HC (P<.001). No difference was found for FDRNa. In conclusion, lithium clearance discloses an increase sodium reabsorption in distal tubule in humans with LC. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320502     DOI: 10.1053/snep.2001.21667

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  2 in total

1.  Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications.

Authors:  G Sansoè; F Wong
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

2.  The Dropsy of Popes (1555-1978): A Bad Prognostic Sign Foreboding of Death.

Authors:  Natale Gaspare De Santo; Carmela Bisaccia; Luca Salvatore De Santo
Journal:  J Relig Health       Date:  2022-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.